BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22918773)

  • 1. Combined PET/MR imaging using (68)Ga-DOTATOC for radiotherapy treatment planning in meningioma patients.
    Thorwarth D; Müller AC; Pfannenberg C; Beyer T
    Recent Results Cancer Res; 2013; 194():425-39. PubMed ID: 22918773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous 68Ga-DOTATOC-PET/MRI for IMRT treatment planning for meningioma: first experience.
    Thorwarth D; Henke G; Müller AC; Reimold M; Beyer T; Boss A; Kolb A; Pichler B; Pfannenberg C
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):277-83. PubMed ID: 21300465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning.
    Gehler B; Paulsen F; Oksüz MO; Hauser TK; Eschmann SM; Bares R; Pfannenberg C; Bamberg M; Bartenstein P; Belka C; Ganswindt U
    Radiat Oncol; 2009 Nov; 4():56. PubMed ID: 19922642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of
    Stade F; Dittmar JO; Jäkel O; Kratochwil C; Haberkorn U; Debus J; Combs SE
    Radiat Oncol; 2018 Apr; 13(1):58. PubMed ID: 29606149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of feasibility and image quality of 68Ga-DOTATOC positron emission tomography/magnetic resonance in comparison with positron emission tomography/computed tomography in patients with neuroendocrine tumors.
    Gaertner FC; Beer AJ; Souvatzoglou M; Eiber M; Fürst S; Ziegler SI; Brohl F; Schwaiger M; Scheidhauer K
    Invest Radiol; 2013 May; 48(5):263-72. PubMed ID: 23385399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of 68Ga-DOTATOC PET/MRI on robotic radiosurgery treatment planning in meningioma patients: first experiences in a single institution.
    Acker G; Kluge A; Lukas M; Conti A; Pasemann D; Meinert F; Anh Nguyen PT; Jelgersma C; Loebel F; Budach V; Vajkoczy P; Furth C; Baur ADJ; Senger C
    Neurosurg Focus; 2019 Jun; 46(6):E9. PubMed ID: 31153151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of cranial meningiomas: comparison of ⁶⁸Ga-DOTATOC PET/CT and contrast-enhanced MRI.
    Afshar-Oromieh A; Giesel FL; Linhart HG; Haberkorn U; Haufe S; Combs SE; Podlesek D; Eisenhut M; Kratochwil C
    Eur J Nucl Med Mol Imaging; 2012 Sep; 39(9):1409-15. PubMed ID: 22669255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated whole-body PET/MR hybrid imaging: clinical experience.
    Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
    Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid PET/MRI of intracranial masses: initial experiences and comparison to PET/CT.
    Boss A; Bisdas S; Kolb A; Hofmann M; Ernemann U; Claussen CD; Pfannenberg C; Pichler BJ; Reimold M; Stegger L
    J Nucl Med; 2010 Aug; 51(8):1198-205. PubMed ID: 20660388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective evaluation of early treatment outcome in patients with meningiomas treated with particle therapy based on target volume definition with MRI and 68Ga-DOTATOC-PET.
    Combs SE; Welzel T; Habermehl D; Rieken S; Dittmar JO; Kessel K; Jäkel O; Haberkorn U; Debus J
    Acta Oncol; 2013 Apr; 52(3):514-20. PubMed ID: 23402336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Effectiveness Analysis of
    Rodriguez J; Martinez G; Mahase S; Roytman M; Haghdel A; Kim S; Madera G; Magge R; Pan P; Ramakrishna R; Schwartz TH; Pannullo SC; Osborne JR; Lin E; Knisely JPS; Sanelli PC; Ivanidze J
    AJNR Am J Neuroradiol; 2023 Jul; 44(7):783-791. PubMed ID: 37290818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging, computed tomography, and 68Ga-DOTATOC positron emission tomography for imaging skull base meningiomas with infracranial extension treated with stereotactic radiotherapy--a case series.
    Graf R; Plotkin M; Steffen IG; Wurm R; Wust P; Brenner W; Budach V; Badakhshi H
    Head Face Med; 2012 Jan; 8():1. PubMed ID: 22217329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET.
    Milker-Zabel S; Zabel-du Bois A; Henze M; Huber P; Schulz-Ertner D; Hoess A; Haberkorn U; Debus J
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):222-7. PubMed ID: 16488553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Use of 68Ga-DOTA-(Tyr3)-Octreotate PET/CT for Improved Target Definition in Radiotherapy Treatment Planning of Meningiomas - A Case Report.
    Grzbiela H; Tarnawski R; D'Amico A; Stąpór-Fudzińska M
    Curr Radiopharm; 2015; 8(1):45-8. PubMed ID: 25808961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Multiphase 68Ga-DOTATOC-PET/CT on therapy management in patients with neuroendocrine tumors.
    Ruf J; Heuck F; Schiefer J; Denecke T; Elgeti F; Pascher A; Pavel M; Stelter L; Kropf S; Wiedenmann B; Amthauer H
    Neuroendocrinology; 2010; 91(1):101-9. PubMed ID: 19996582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy.
    Putzer D; Gabriel M; Henninger B; Kendler D; Uprimny C; Dobrozemsky G; Decristoforo C; Bale RJ; Jaschke W; Virgolini IJ
    J Nucl Med; 2009 Aug; 50(8):1214-21. PubMed ID: 19617343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of ⁶⁸Ga-DOTATOC-PET/CT and PET/MRI hybrid systems in patients with cranial meningioma: Initial results.
    Afshar-Oromieh A; Wolf MB; Kratochwil C; Giesel FL; Combs SE; Dimitrakopoulou-Strauss A; Gnirs R; Roethke MC; Schlemmer HP; Haberkorn U
    Neuro Oncol; 2015 Feb; 17(2):312-9. PubMed ID: 25008094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A strategy for multimodal deformable image registration to integrate PET/MR into radiotherapy treatment planning.
    Leibfarth S; Mönnich D; Welz S; Siegel C; Schwenzer N; Schmidt H; Zips D; Thorwarth D
    Acta Oncol; 2013 Oct; 52(7):1353-9. PubMed ID: 23879651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of [
    Milosevic A; Styczen H; Grueneisen J; Li Y; Weber M; Fendler WP; Kirchner J; Damman P; Wrede K; Lazaridis L; Glas M; Guberina M; Eckstein A; Blau T; Herrmann K; Umutlu L; Forsting M; Deuschl C; Schaarschmidt B
    J Nucl Med; 2023 Aug; 64(8):1185-1190. PubMed ID: 37385668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First intraindividual comparison of contrast-enhanced MRI, FET- and DOTATOC- PET in patients with intracranial meningiomas.
    Dittmar JO; Kratochwil C; Dittmar A; Welzel T; Habermehl D; Rieken S; Giesel FL; Haberkorn U; Debus J; Combs SE
    Radiat Oncol; 2017 Nov; 12(1):169. PubMed ID: 29110720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.